Clinical activity and safety of the EGFR mutant-specific inhibitor, BI 1482694 (HM61713), in patients with T790M-positive NSCLC | boehringer-ingelheim.pt

DOWNLOAD PDF (891.2 KB)

Clinical activity and safety of the EGFR mutant-specific inhibitor, BI 1482694 (HM61713), in patients with T790M-positive NSCLC

Transferir o PDFof Clinical activity and safety of the EGFR mutant-specific inhibitor, BI 1482694 (HM61713), in patients with T790M-positive NSCLC